Reference priceKRW ₩850,500.00Original source price: INR 52,500.00. Converted estimates are available by currency selection.
| Brand | Abraxane |
|---|---|
| Manufacturer | CELGENE |
| Prescription required | Yes |
Abraxane 5mg/ml polvo,1vial x 20ml (paclitaxel protein-bound)
paclitaxel protein-bound
Description
Abraxane 5mg/ml polvo,1vial x 20ml (paclitaxel protein-bound) is a medicine catalog record in the MediPriceHub database. Active ingredient: paclitaxel protein-bound. Clinical use summary: See the Benefits field on this page for the product-specific indication or intended use. That field is kept separate from catalog metadata so users can distinguish clinical information from packaging information. Manufacturer or supplier: CELGENE. Therapeutic category: Medicine Library > Oncology Medicines > Pancreatic Cancer Medicines. Pack information: 5 / (100 / 20 ) / 1. Origin country or market: Spain. This page is for medicine catalog reference only and should be read together with the approved prescribing information in the patient or buyer's country.Benefits
Paclitaxel is a microtubule inhibitor indicated for the treatment of: Metastatic breast cancer, after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy. Prior therapy should have included an anthracycline unless clinically contraindicated. Locally advanced or metastatic non-small cell lung cancer (NSCLC), as first-line treatment in combination with carboplatin, in patients who are not candidates for curative surgery or radiation therapy. Metastatic adenocarcinoma of the pancreas as first-line treatment, in combination with gemcitabine.How to Use
Use paclitaxel protein-bound under the supervision of a qualified healthcare professional. It should be prepared and administered only by trained healthcare professionals in a setting appropriate for injectable or infusion medicines. Do not start, stop, change the dose, split or crush a dosage form, mix with other medicines, or repeat a course unless the approved product information or a clinician confirms that it is appropriate. Check the local prescribing information for age limits, dose adjustments, missed-dose instructions, storage after opening or reconstitution, and monitoring requirements.Specification
Active ingredient: paclitaxel protein-bound. Pack size: 5 / (100 / 20 ) / 1. Pack unit: bottle. Manufacturer: CELGENE. Origin country: Spain. Source category: Medicine Library > Oncology Medicines > Pancreatic Cancer Medicines. Availability, prescription status, storage, and exact approved use may vary by country. Check the local product information before clinical or procurement decisions.Side Effects
Cancer medicines may cause fatigue, nausea, vomiting, diarrhea or constipation, appetite changes, mouth sores, rash, changes in blood counts, infection risk, liver or kidney test changes, bleeding risk, neuropathy, infusion reactions, or organ-specific toxicity depending on the medicine. Injectable and infusion products may also cause administration-site pain, swelling, infection, infusion reactions, or hypersensitivity. Seek urgent medical care for severe allergic symptoms, breathing difficulty, fainting, severe skin reactions, chest pain, confusion, serious bleeding, signs of infection, or rapidly worsening symptoms. The approved local prescribing information is the controlling source for the complete adverse-reaction profile.이 정보는 참고용입니다. 의약품 사용 전 의료 전문가와 상담하세요.